Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.
about
Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer TherapyA nanocomposite of Au-AgI core/shell dimer as a dual-modality contrast agent for x-ray computed tomography and photoacoustic imaging.Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.Supramolecular PEGylated Dendritic Systems as pH/Redox Dual-Responsive Theranostic Nanoplatforms for Platinum Drug Delivery and NIR Imaging.Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer.Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.Use of single chain antibody derivatives for targeted drug delivery.E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy.
P2860
Q28394225-04FA735C-E1E3-4CE2-984E-1A731E29ACBFQ30366905-95281452-E55A-4A30-BDB9-F2ED2AE78018Q33703133-00A63056-59C6-455A-90B2-51C170A60C72Q37045940-A192C5B7-241E-4C08-9260-7DF62150828BQ37642463-FACB6A99-0FE6-46D8-97E1-2A4E9A303A5FQ38658279-91FBA5F4-DD1C-4FE7-87A1-FFD48CA90D2DQ38812845-E0E8F5BA-00CB-4088-8B90-33182C0357E4Q38850046-6CB5C204-8464-434C-92DF-0B772A49E283Q52647653-8ED281B0-8982-445A-B107-4026D6890330
P2860
Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Theranostic nanoparticles carr ...... s following systemic delivery.
@ast
Theranostic nanoparticles carr ...... s following systemic delivery.
@en
Theranostic nanoparticles carr ...... s following systemic delivery.
@nl
type
label
Theranostic nanoparticles carr ...... s following systemic delivery.
@ast
Theranostic nanoparticles carr ...... s following systemic delivery.
@en
Theranostic nanoparticles carr ...... s following systemic delivery.
@nl
prefLabel
Theranostic nanoparticles carr ...... s following systemic delivery.
@ast
Theranostic nanoparticles carr ...... s following systemic delivery.
@en
Theranostic nanoparticles carr ...... s following systemic delivery.
@nl
P2093
P2860
P356
P1433
P1476
Theranostic nanoparticles carr ...... s following systemic delivery.
@en
P2093
Christina Ward
Erica N Bozeman
Malgorzata Lipowska
Periasamy Selvaraj
Weiping Qian
P2860
P356
10.7150/THNO.10350
P577
2015-01-01T00:00:00Z